These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date 2006-001782-42 Efficacy and tolerability of a new oral extended-release formulation containing Low Molecular Weight Heparin (CB-01-05-MMX), administered as add-on therapy to oral mesalazine or other 5-ASA derivative... 2007-12-19 bad-data
Listed as ongoing, but also has a completion date 2006-004776-12 Efficacy and safety of oral budesonide-MMX™ (CB-01-02) 6 mg and 9 mg extended release tablets in patients with mild or moderate active ulcerative colitis. A multicentre, randomised, double-blind, dou... 2010-12-13 bad-data
Completed, but no date 2007-007702-30 Feasibility and safety of Infliximab enema treatment in patients with active left-sided ulcerative colitis. An open-label, non comparative, pilot study. bad-data
Not reported 2008-003913-28 Randomised, double-blind,multicentre,12 months extension study to evaluate the safety and the efficacy of daily Budesonide MMX 6mg vs placebo in the maintenance of remission in subjects with ulcerativ... 2011-05-16 due-trials
Not reported 2011-001173-24 Colon staining efficacy of single oral doses of methylene blue MMX modified release tablets administered to patients undergoing colonoscopy 2012-01-16 due-trials
Not reported 2011-005693-36 Intraepithelial neoplasia detection rate after single oral dose of methylene blue MMX modified release tablets administered to patients with long standing ulcerative colitis undergoing colonoscopy 2012-07-04 due-trials
Completed, but no date 2011-005694-23 Polyp detection rate after single oral dose of methylene blue MMX(R) modified release tablets administered to subjects undergoing outpatients colonoscopy bad-data
Listed as ongoing, but also has a completion date 2012-003983-32 The safety and efficacy of Methylene Blue MMX® modified release tablets administered to subjects undergoing screening or surveillance colonoscopy. 2016-10-27 bad-data
Completed, but no date 2013-000452-18 Staining efficacy and safety of Methylene Blue enemas in patients undergoing flexible rectosigmoidoscopy bad-data
Completed, but no date 2013-000634-35 Effect of oral administration of Methylene Blue MMX® tablets on double-stranded DNA damage assessed by γH2AX analysis of colon biopsy samples bad-data
Other 2016-004977-42 A Phase II, multicentre, randomised, double-blind, placebo controlled, proof of concept study of efficacy and safety of Rifamycin SV-MMX® 600 mg tablets administered three or two times daily to patien... not-yet-due